Shalby Ltd

Shalby Ltd's Management Committee has approved availing working capital facilities totaling ₹129.70 crore from Kotak Mahindra Bank Limited. This includes ₹119.70 crore for its overseas step-down subsidiary, Shalby Advanced Technologies, Inc., USA, to meet its working capital requirements. The remaining ₹10 crore will be availed by Shalby Ltd itself, through Working Capital Demand Loan (WCDL) or Cash Credit facilities. The company states that providing the necessary support for the subsidiary's credit facilities is in its overall interest, and no significant financial or operational impact is foreseen from this transaction.

Shalby Ltd has revised the date of its Board Meeting, originally scheduled for August 5, 2026, to August 12, 2026. The meeting is to consider the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). Due to unavoidable exigencies, the meeting date has been postponed. Consequently, the trading window, which was closed from July 1, 2026, will remain closed and reopen 48 hours after the conclusion of the rescheduled Board Meeting, in compliance with the company's Code of Conduct for Prohibition of Insider Trading.

Shalby Limited announced the exercise of 6,000 employee stock options under its 2021 ESOP scheme on July 20, 2026. The shares are being transferred from the secondary market via the Shalby Limited Employee Welfare Trust, resulting in no change to the company's paid-up equity share capital. The exercise price was ₹100 per option, realizing ₹6,00,000. A total of 85,500 options were initially granted on July 12, 2024, with 33,000 vested on July 12, 2026. The options can be exercised within one year of vesting. Diluted EPS is reported at ₹3.23 for the year ended March 31, 2026.

Shalby Ltd has announced that its Board of Directors will convene on August 5, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026, on both standalone and consolidated bases. Additionally, the meeting will address any other business as permitted by the Chair. The company has also informed its insiders about the closure of the trading window, effective July 1, 2026, which will remain shut for 48 hours post the public announcement of these financial results.

Shalby Ltd has announced the disposal of arbitration proceedings against Dr. Viral Shah and Dr. Praveen Saxena. The orders were issued by the Sole Arbitrator, Hon'ble Justice M. S. Parikh (Retd.), on June 26, 2026, following joint withdrawal/settlement filings by both parties. The company states there is no quantifiable impact on its financial or operational activities, as the matters are fully settled. This development resolves ongoing legal disputes, bringing closure to these arbitration cases.

Shalby Ltd has announced a closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. All company insiders have been advised against trading in Shalby Ltd's securities during this period.

Shalby Limited issued a clarification regarding a typographical error in its May 27, 2026 Board Meeting announcement. The correct Cost Auditor appointed for the audit of cost accounts for FY 2026-27 is S A & Associates, Ahmedabad (Firm Registration No. 000347), replacing the previously mentioned M/s. Borad Sanjay B & Associates. S A & Associates is a well-established firm specializing in Cost Auditing and Management Consultancy, led by FCMA Sanjay B. Borad, with over two decades of experience across various industries including Metal, FMCG, Chemicals, and Healthcare.

Shalby Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board meeting, which commenced at 5:10 p.m. and concluded at 6:09 p.m., also saw the appointment of M/s. Borad Sanjay B & Associates as the cost accountant for FY 2026-27. The board did not recommend any dividend for the financial year 2025-26. The 22nd Annual General Meeting is scheduled for September 10, 2026.

Shalby Ltd. announced that its step-down subsidiary, Ninegen Lifecare Pvt. Ltd., has been struck off from the Register of Companies by the Ministry of Corporate Affairs, effective May 12, 2026. This action means Ninegen Lifecare is no longer a subsidiary of PK Healthcare Pvt. Ltd and consequently, no longer a step-down subsidiary of Shalby Ltd. The company has confirmed that this strike-off will not have any material financial impact on its business, operations, or financials.

Shalby Ltd has announced that a meeting of the Board of Directors is scheduled for May 27, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The board will also consider recommending a dividend on the equity shares for the financial year 2025-26, subject to member approval. The trading window for the company's equity shares has been closed from April 1, 2026, and will remain closed until 48 hours after the financial results are made public.